CLOV — Clover Health Investments Income Statement
0.000.00%
Last trade - 00:00- $1.75bn
- $1.53bn
- $1.37bn
- 49
- 32
- 99
- 62
Annual income statement for Clover Health Investments, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 1,472 | 1,097 | 1,261 | 1,371 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6.86 | 2,109 | 1,360 | 1,466 | 1,417 |
| Operating Profit | -6.86 | -637 | -263 | -205 | -45.7 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -6.74 | -588 | -255 | -210 | -46.3 |
| Net Income After Taxes | -6.74 | -588 | -255 | -210 | -46.3 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -6.74 | -588 | -340 | -213 | -43 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -6.74 | -588 | -340 | -213 | -43 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.065 | -1.42 | -0.584 | -0.382 | -0.094 |